These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 33172933)

  • 1. Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
    Wang Y; Zhao G; Condello S; Huang H; Cardenas H; Tanner EJ; Wei J; Ji Y; Li J; Tan Y; Davuluri RV; Peter ME; Cheng JX; Matei D
    Cancer Res; 2021 Jan; 81(2):384-399. PubMed ID: 33172933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-linked kinase-frizzled 7 interaction maintains cancer stem cells to drive platinum resistance in ovarian cancer.
    Atwani R; Nagare RP; Rogers A; Prasad M; Lazar V; Sandusky G; Tong Y; Pin F; Condello S
    J Exp Clin Cancer Res; 2024 Jun; 43(1):156. PubMed ID: 38822429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness.
    Muñoz-Galván S; Felipe-Abrio B; Verdugo-Sivianes EM; Perez M; Jiménez-García MP; Suarez-Martinez E; Estevez-Garcia P; Carnero A
    Mol Cancer; 2020 Jan; 19(1):7. PubMed ID: 31926547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Frizzled-7 Decreases Stemness and Chemotherapeutic Resistance in Gastric Cancer Cells by Suppressing Myc Expression.
    Cheng Y; Li L; Pan S; Jiang H; Jin H
    Med Sci Monit; 2019 Nov; 25():8637-8644. PubMed ID: 31733054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
    Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
    Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway.
    Asad M; Wong MK; Tan TZ; Choolani M; Low J; Mori S; Virshup D; Thiery JP; Huang RY
    Cell Death Dis; 2014 Jul; 5(7):e1346. PubMed ID: 25032869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1-3p enhances the sensitivity of ovarian cancer cells to ferroptosis by targeting FZD7.
    Zhang D; Qu B; Hu B; Cao K; Shen H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 47(11):1512-1521. PubMed ID: 36481629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer.
    Zhang Z; Xu Y; Zhao C
    Cancer Med; 2021 May; 10(10):3332-3345. PubMed ID: 33934523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-canonical Fzd7 signaling contributes to breast cancer mesenchymal-like stemness involving Col6a1.
    Yin P; Bai Y; Wang Z; Sun Y; Gao J; Na L; Zhang Z; Wang W; Zhao C
    Cell Commun Signal; 2020 Sep; 18(1):143. PubMed ID: 32894152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.
    Kaipio K; Chen P; Roering P; Huhtinen K; Mikkonen P; Östling P; Lehtinen L; Mansuri N; Korpela T; Potdar S; Hynninen J; Auranen A; Grénman S; Wennerberg K; Hautaniemi S; Carpén O
    J Pathol; 2020 Feb; 250(2):159-169. PubMed ID: 31595974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
    Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
    Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting PAX8 sensitizes ovarian cancer cells to ferroptosis by inhibiting glutathione synthesis.
    Luo Y; Liu X; Chen Y; Tang Q; He C; Ding X; Hu J; Cai Z; Li X; Qiao H; Zou Z
    Apoptosis; 2024 Oct; 29(9-10):1499-1514. PubMed ID: 38853202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell-like features in cisplatin-resistant ovarian cancer.
    Zhang Q; Wang J; Qiao H; Huyan L; Liu B; Li C; Jiang J; Zhao F; Wang H; Yan J
    J Cell Mol Med; 2021 May; 25(9):4395-4407. PubMed ID: 33797839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma.
    Tan M; Asad M; Heong V; Wong MK; Tan TZ; Ye J; Kuay KT; Thiery JP; Scott C; Huang RY
    Mol Oncol; 2019 Apr; 13(4):757-780. PubMed ID: 30548372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.